Condition
    Strong Evidence
    Effectiveness 3/5

    Magnesium for Chronic Fatigue Syndrome (ME/CFS)

    Interest in magnesium for ME/CFS dates to a small 1991 trial reporting improved energy after intramuscular injection. That result has not been reliably replicated with oral dosing, so the case rests largely on correcting documented deficiency.

    Overview

    Interest in magnesium for ME/CFS dates to a small 1991 trial reporting improved energy after intramuscular injection. That result has not been reliably replicated with oral dosing, so the case rests largely on correcting documented deficiency.

    Verdict

    Insufficient evidence

    How It Works

    Magnesium is essential for ATP function: the biologically active form of adenosine triphosphate is the Mg-ATP complex, so mitochondrial energy transfer cannot proceed normally without adequate magnesium. This is the intuitive rationale for its use in fatigue states. Whether that rationale applies to ME/CFS depends on whether people with the condition are actually depleted. Red cell magnesium has been reported as low in some cohorts and normal in others, and serum magnesium is a poor marker of total body stores, which leaves the premise unsettled.

    Dosing & Protocol

    Typical dose

    Recommended dose
    400-600mg elemental magnesium daily
    Expected timeframe
    Not established for the syndrome

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient: a single small 1991 trial of weekly intramuscular magnesium sulphate reported benefit and was not replicated, and oral magnesium at 300-400 mg daily has never been shown to improve CFS/ME fatigue. Correcting a documented deficiency is reasonable; treating the syndrome with magnesium is not supported. Pacing remains the mainstay.
    titration
    Not applicable
    starting dose
    Not applicable as a treatment

    Evidence

    What the studies say

    The frequently cited evidence is a 1991 Lancet randomised trial in which weekly intramuscular magnesium sulphate for six weeks improved energy and emotional state in patients with chronic fatigue syndrome relative to placebo. Subsequent attempts to replicate the red cell magnesium deficiency finding produced conflicting results, and no adequately powered oral supplementation trial has confirmed benefit. Current ME/CFS clinical guidance does not recommend magnesium as a treatment. The defensible use is narrow: test magnesium status, correct a documented deficiency, and consider it for co-occurring problems such as muscle cramping or poor sleep. Pacing and management of post-exertional malaise remain the core of care.

    The Effect of Magnesium Supplementation on Primary Insomnia in Elderly: A Double-Blind Placebo-Controlled Clinical Trial

    Score: 7/10
    2012
    rct
    n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium supplementation improved subjective measures of insomnia, sleep efficiency, sleep time, and sleep onset latency in elderly subjects.

    View source

    Safety

    Caveats

    Evidence does not support magnesium as a CFS/ME treatment, and post-exertional malaise means unproven regimens can displace pacing. Safety ceiling: 350 mg/day supplemental upper limit; diarrhoea above this worsens fatigue through dehydration. Avoid without advice in renal impairment. Separate from antibiotics and levothyroxine by four hours.

    Less likely to help if

    Anyone with normal magnesium status - which is most people with CFS/ME - should expect no change in fatigue.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.